Adjuvant rituximab improves sensory ataxia in CIDP-related Sjögren syndrome

https://casereports.bmj.com/content/13/8/e234681 https://www.ncbi.nlm.nih.gov/pubmed/32847874?dopt=Abstract TITLE: Adjuvant rituximab improves sensory ataxia in CIDP-related Sjögren syndrome. DESCRIPTION: Related Articles Adjuvant rituximab improves sensory ataxia in CIDP-related Sjögren syndrome. BMJ Case Rep. 2020 Aug 26;13(8): Authors: Rocha R, Correia F, Santos A, Martins J Abstract Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune neuropathy characterised by insidious onset, progressive course, […]